WHC is still in active development. Read this to understand our approach.
depiction of ZKLXUUYLEHCAMF-UHFFFAOYSA-N.svg
isomerdesign

6-Methoxy-17-methyl-...

Check on isomerdesign

pubchem

Oripavine

Check on pubchem

drugmap

ORIPAVINE

Check on drugmap

wiki

Oripavine

Check on wiki

Data

InChI: InChI=1S/C18H19NO3/c1-19-8-7-18-11-4-6-14(21-2)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19/h3-6,12,17,20H,7-9H2,1-2H3

Synonyms: 467-04-9, 3-O-demethyl-thebaine, DTXSID10196908, SCHEMBL19880919, 575AOU51CR,4-27-00-02270 (Beilstein Handbook Reference),(4R,7aR,12bS)-7-methoxy-3-methyl-2,4,7a,13-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-9-ol,CODEINE HYDROCHLORIDE DIHYDRATE IMPURITY L [EP IMPURITY], UNII-575AOU51CR,CODEINE MONOHYDRATE IMPURITY L [EP IMPURITY], 4-27-00-02270 (Beilstein Handbook Reference),6,7,8,14-TETRADEHYDRO-4,5.ALPHA.-EPOXY-6-METHOXY-17-METHYLMORPHINAN-3-OL, 467-04-9,DEA No. 9330,CHEBI:7782,DTXSID10196908,3-O-Demethylthebaine,CODEINE PHOSPHATE HEMIHYDRATE IMPURITY L [EP IMPURITY], SCHEMBL37889,Oripavine,(1S,5R,13R)-14-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0?,??.0?,??.0?,??]octadeca-7,9,11(18),14,16-pentaen-10-ol,6,7,8,14-Tetradehydro-4,5alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol (Oripavine), CHEBI:7782, Morphinan-3-ol, 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methyl-,SCHEMBL37889,UNII-575AOU51CR, Oripavine 0.1 mg/ml in Methanol, 6,7,8,14-Tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methyl-morphinan-3-ol,6,7,8,14-Tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methyl-morphinan-3-ol, BRN 0046094,Oripavine 0.1 mg/ml in Methanol,HSDB 8324, CHEMBL437602,Morphinan-3-ol, 6,7,8,14-tetradehydro-4,5-epoxy-6-methoxy-17-methyl-, (5.alpha.)-,SCHEMBL19880919, EINECS 207-385-6,CHEMBL437602, (5alpha)-6,7,8,14-Tetradehydro-4,5-epoxy-6-methoxy-17-methylmorphinan-3-ol,Morphinan-3-ol, 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methyl-,MORPHINE SULFATE IMPURITY C [EP IMPURITY],Q420639,ORIPAVINE [MI],575AOU51CR, ZKLXUUYLEHCAMF-UUWFMWQGSA-N,EINECS 207-385-6, DEA No. 9330,(4R,7aR,12bS)-7-Methoxy-3-methyl-2,3,4,7a-tetrahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinolin-9-ol,BRN 0046094,(5α)-6-Methoxy-17-methyl-6,7,8,14-tetradehydro-4,5-epoxymorphinan-3-ol,IDS-NO-010,(5alpha)-6,7,8,14-Tetradehydro-4,5-epoxy-6-methoxy-17-methylmorphinan-3-ol,C06175,6-Methoxy-17-methyl-6,7,8,14-tetradehydro-4,5α-epoxymorphinan-3-ol

Estimated data

Solubility: -3.117 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 75.3% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.